StockGlow

Kailera Therapeutics, Inc. (KLRA)

Kailera Therapeutics, Inc.

$16.78-0.02%Healthcare
Compare KLRA with
StockGlow Score
20
Leaning Bearish
BearishBullish
1 year ago-35.5%

The outlook

Kailera Therapeutics, Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 3% of the way from its 52-week low to high, avg target +154% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +154% vs current price

Analyst price target

~12-month · 5 analysts
$42.60average target+153.9% vs now
Now $16.78
Low $30.00High $57.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$2.17B
52-wk high
$28.23
52-wk low
$16.39
50-day avg
$20.18
200-day avg
$21.19
Trailing P/E
—

Similar stocks

COAGHemab Therapeutics Holdings, Inc.$46.28-2.52%PBLSParabilis Medicines, Inc.$32.45+0.53%MANEVeradermics, Incorporated$105.83+1.15%ALMRAlamar Biosciences, Inc.$24.87-0.82%SPTXSeaport Therapeutics, Inc.$19.98-1.67%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy